Back Bay Life Science Advisors
Market Insights
Investment Banking Analytics Strategic Advisory
Company Global Partnerships Meet Our Team Careers Resource Library Locations
DNB//Back Bay Partnership DNB//Back Bay Healthcare Team
Corporate Contact Toronto Office
OUR SERVICES Investment Banking Analytics Strategic Advisory About Company Global Partnerships Meet Our Team Careers Resource Library Locations Market Insights DNB//BACK BAY DNB//Back Bay Partnership DNB//Back Bay Healthcare Team Contact Corporate Contact Toronto Office
Back Bay Life Science Advisors

DNB//BACK BAY Weekly Market Updates

Market Update for Week of May 30, 2025

Market Update for Week of May 30, 2025

The Week at a Glance:

Markets Notch Minor Gains: US equities finished the week slightly up due to promising inflation numbers and the Court of International Trade ruling that the current administration overstepped with its implementation of tariffs; however, the White House’s successful appeal means that tariffs will remain in place until a final ruling is made

No Pain, More Gains: Eli Lilly finished the week up 3.8% spurred by the news of its $1.0B acquisition of SiteOne Therapeutics, which includes SiteOne’s Phase 2-ready oral Nav1.8 inhibitor for the treatment of pain

NIH Stares Down Deep Cuts: The HHS released details of President Trump’s FY2026 budget request cutting the NIH discretionary budget by ~40.0% and reducing the agency’s 27 institutes/centers to just eight, a move that some are claiming could have dire consequences to US leadership in biomedicine

READ FULL UPDATE >

1
Previous Next
Market Update for Week of May 30, 2025
 

545 Boylston Street
12th Floor
Boston, MA 02116

+1 617.236.0954 Office
+1 617.236.1215 Fax

Boston | Toronto

 

OUR SERVICES


STRATEGIC ADVISORY >>

  • Life sciences corporate growth and market access strategy

  • Franchise, business unit & therapeutic area strategy

  • Competitive intelligence

  • Asset & development prioritization

  • Platform implementation

  • Payor/Pricing strategy

  • Contracting strategy

  • Launch & counter-launch strategy

  • Product positioning, branding & messaging

  • Life-cycle management

  • Corporate growth strategy

  • Liquidity & exit planning

INVESTMENT BANKING >>

FINANCING >>

  • Mergers, acquisitions & divestitures

  • IPO preparedness and execution

  • Private & public company, cross-border execution

  • Financing support

  • Fairness opinion, valuation

  • Treasury solutions

  • Fixed income origination

  • Equity and debt capital markets

  • Liquidity and exit planning

  • Due diligence and valuation

  • Divestments

  • Licensing (buy and sell side)

  • Partnering

  • Recapitalization

  • New Company formation

  • Investment Grade Bonds

  • High yield and convertible bonds

  • Debt and restructuring

Subscribe

Sign up with your email address to receive weekly market updates.

We respect your privacy.

Thank you for subscribing.


©2025 Back Bay Life Science Advisors | Privacy Policy